Skip to content
Disclosery

EXANE DERIVATIVES: DOW position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DOW, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 43,346 DOW shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 43,346 shares
    Change vs previous 13F +20,045 shares

    1.29% of the 13F portfolio, value $2,236,631.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 23,301 shares
    Change vs previous 13F +21,993 shares

    0.42% of the 13F portfolio, value $1,484,648.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,308 shares
    Change vs previous 13F +123 shares

    0.02% of the 13F portfolio, value $74,187.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,185 shares
    Change vs previous 13F -18,436 shares

    0.02% of the 13F portfolio, value $68,206.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 19,621 shares
    Change vs previous 13F not available

    0.29% of the 13F portfolio, value $1,230,209.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).